世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000042576

高分子原薬CDMO市場(2025 - 2033)

Grand View Research Inc.

Large Molecule Drug Substance CDMO Market (2025 - 2033)

発刊日 2025/09

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000042576

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

規模、シェア、動向分析レポート:製品別、サービス別 (受託製造、受託開発)、ソース別、最終用途別、地域別、およびセグメント予測

高分子原薬CDMO市場の概要

世界の高分子原薬CDMO市場規模は、2024年に520億2,000万ドルと推定され、2025年から2033年にかけて7.71%のCAGRで成長し、2033年までに1,014億1,000万ドルに達すると予測されます。この市場は、生物製剤需要の増加、バイオプロセス技術の進歩、新たなコスト効率とリスク軽減、製薬会社やバイオテクノロジー企業による設備投資の増加によって大幅な成長を遂げています。

レポート詳細

目次

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Service
1.2.3. Source
1.2.4. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Large Molecule Drug Substance CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Large Molecule Drug Approvals
3.2.1.2. Technological Advancements In Bioprocessing
3.2.1.3. Rising Incidence of Infectious Diseases,
3.2.1.4. Higher Capital Investments by Pharma and Biotech Firms In Advanced Technologies for Establishing Partnerships With CDMOs
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance Issues While Outsourcing
3.2.2.2. Changing Scenarios In Developing Countries
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis

Chapter 4. Large Molecule Drug Substance CDMO Market: Product Estimates & Trend Analysis
4.1. Large Molecule Drug Substance CDMO Market, By Product: Segment Dashboard
4.2. Large Molecule Drug Substance CDMO Market, By Product: Movement Analysis
4.3. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
4.4. Biologics
4.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Biosimilar
4.5.1. Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Large Molecule Drug Substance CDMO Market: Service Estimates & Trend Analysis
5.1. Large Molecule Drug Substance CDMO Market, By Service: Segment Dashboard
5.2. Large Molecule Drug Substance CDMO Market, By Service: Movement Analysis
5.3. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
5.4. Contract Manufacturing
5.4.1. Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. Clinical
5.4.2.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.3. Commercial
5.4.3.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Contract Development
5.5.1. Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Cell Line Development
5.5.2.1. Cell Line Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Process Development
5.5.3.1. Process Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Large Molecule Drug Substance CDMO Market: Source Estimates & Trend Analysis
6.1. Large Molecule Drug Substance CDMO Market, By Source: Segment Dashboard
6.2. Large Molecule Drug Substance CDMO Market, By Source: Movement Analysis
6.3. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By Source, 2021 - 2033 (USD Million)
6.4. Mammalian
6.4.1. Mammalian Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Microbial
6.5.1. Microbial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Large Molecule Drug Substance CDMO Market: End Use Estimates & Trend Analysis
7.1. Large Molecule Drug Substance CDMO Market, By End-Use: Segment Dashboard
7.2. Large Molecule Drug Substance CDMO Market, By End-Use: Movement Analysis
7.3. Large Molecule Drug Substance CDMO Market Estimates & Forecasts, By End-Use, 2021 - 2033 (USD Million)
7.4. Biotech Companies
7.4.1. Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. CRO
7.5.1. CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Others
7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Large Molecule Drug Substance CDMO Market: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2033
8.3. North America
8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.2. U.S
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.3. Canada
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.3.4. Mexico
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Europe
8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.2. UK
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3. Germany
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4. France
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.5. Italy
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.6. Spain
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.7. Denmark
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. Japan
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5. Australia
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Latin America
8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. Brazil
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. Argentina
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. MEA
8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.2. South Africa
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.3. UAE
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.4. Saudi Arabia
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.6. Qatar
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.7. Oman
8.7.7.1. Key Country Dynamics
8.7.7.2. Competitive Scenario
8.7.7.3. Regulatory Framework
8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape
9.1. Key Participant Categorization
9.1.1. Market Leaders
9.1.2. Emerging Players
9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
9.3. Company Profiles
9.3.1. Eurofins Scientific
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. WuXi Biologics
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Samsung Biologics
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Catalent, Inc.
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Rentschler Biopharma SE
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. AGC Biologics
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Recipharm AB
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Siegfried Holding AG
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Boehringer Ingelheim
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. FUJIFILM Diosynth Biotechnologies
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives

List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 4. Global Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 5. Global Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 6. Global Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 7. North America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 8. North America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 9. North America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 10. North America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 11. North America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 12. U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 13. U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 14. U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 15. U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 16. Canada Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 17. Canada Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 18. Canada Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 19. Canada Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 20. Mexico Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 21. Mexico Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 22. Mexico Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 23. Mexico Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 24. Europe Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 25. Europe Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 26. Europe Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 27. Europe Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 28. Europe Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 29. UK Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 30. UK Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 31. UK Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 32. UK Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 33. Germany Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 34. Germany Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 35. Germany Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 36. Germany Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 37. France Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 38. France Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 39. France Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 40. France Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 41. Italy Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 42. Italy Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 43. Italy Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 44. Italy Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 45. Spain Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 46. Spain Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 47. Spain Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 48. Spain Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 49. Denmark Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 50. Denmark Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 51. Denmark Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 52. Denmark Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 53. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 54. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 55. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 56. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 57. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 58. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 59. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 60. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 61. Asia Pacific Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 62. Asia Pacific Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 63. Asia Pacific Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 64. Asia Pacific Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 65. Asia Pacific Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 66. Japan Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 67. Japan Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 68. Japan Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 69. Japan Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 70. China Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 71. China Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 72. China Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 73. China Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 74. India Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 75. India Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 76. India Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 77. India Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 78. Australia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 79. Australia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 80. Australia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 81. Australia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 82. Thailand Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 83. Thailand Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 84. Thailand Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 85. Thailand Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 86. South Korea Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 87. South Korea Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 88. South Korea Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 89. South Korea Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 90. Latin America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 91. Latin America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 92. Latin America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 93. Latin America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 94. Latin America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 95. Brazil Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 96. Brazil Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 97. Brazil Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 98. Brazil Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 99. Argentina Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 100. Argentina Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 101. Argentina Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 102. Argentina Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 103. Middle East & Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
Table 104. Middle East & Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 105. Middle East & Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 106. Middle East & Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 107. Middle East & Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 108. South Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 109. South Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 110. South Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 111. South Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 112. Saudi Arabia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 113. Saudi Arabia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 114. Saudi Arabia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 115. Saudi Arabia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 116. UAE Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 117. UAE Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 118. UAE Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 119. UAE Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 120. Kuwait Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 121. Kuwait Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 122. Kuwait Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 123. Kuwait Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 124. Oman Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 125. Oman Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 126. Oman Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 127. Oman Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 128. Qatar Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 129. Qatar Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 130. Qatar Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 131. Qatar Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 132. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 133. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 134. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 135. Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 136. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 137. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
Table 138. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by Source, 2021 - 2033 (USD Million)
Table 139. Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 Large Molecule Drug Substance Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 Large Molecule Drug Substance CDMO Market: Product outlook and key takeaways
Fig. 20 Large Molecule Drug Substance CDMO Market: Product movement analysis
Fig. 21 Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Biosimilar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 Large Molecule Drug Substance CDMO Market: Service outlook and key takeaways
Fig. 24 Large Molecule Drug Substance CDMO Market: Service movement analysis
Fig. 25 Contract Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 27 Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 28 Contract Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 29 Cell Line Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 30 Process Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 31 Large Molecule Drug Substance CDMO Market: Source outlook and key takeaways
Fig. 32 Large Molecule Drug Substance CDMO Market: Source movement analysis
Fig. 33 Mammalian Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Microbial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 35 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 36 Large Molecule Drug Substance CDMO Market: End Use outlook and key takeaways
Fig. 37 Large Molecule Drug Substance CDMO Market: End Use movement analysis
Fig. 38 Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Regional Marketplace: Key Takeaways
Fig. 42 North America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 U.S. Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Canada Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Mexico Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 49 Europe Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 UK Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Germany Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 France Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Italy Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Spain Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Denmark Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Sweden Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Norway Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 66 Asia Pacific Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Japan Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 China Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 India Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Australia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Thailand Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 South Korea Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 79 Latin America Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Brazil Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Argentina Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 84 MEA Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 South Africa Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 UAE Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Saudi Arabia Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Kuwait Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Qatar Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Oman Large Molecule Drug Substance CDMO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 97 Key company categorization
Fig. 98 Service heat map analysis
Fig. 99 Strategic framework

この商品のレポートナンバー

0000042576

最近見たレポート

膝軟骨修復の世界市場レポート(2025年)

Knee Cartilage Repair Global Market Report 2025

2025/04/01

4,490 USD

分娩モニタリング装置の世界市場レポート(2025年)

Intrapartum Monitoring Devices Global Market Report 2025

2025/04/01

4,490 USD

ヘルスケア受託開発・製造機関(CDMO)市場(2025 - 2033)

Healthcare Contract Development And Manufacturing Organization Market (2025 - 2033)

2025/09/01

5,950 USD

高磁場および超高磁場NMR分光法市場規模、シェア、動向分析レポート:セグメント予測、2025‐2035

High And Ultra-high-field Nuclear Magnetic Resonance Spectroscopy Market Size, Share & Trends Analysis Report, And Segment Forecasts (2025 - 2035)

2025/09/01

5,950 USD

生理食塩水市場(2025‐2033)

Physiological Saline Market (2025 - 2033)

2025/09/01

5,950 USD

足と足首の外傷市場(2025 - 2033)

Foot And Ankle Trauma Market (2025 - 2033)

2025/09/01

5,950 USD

TOP